BIORESOURCE HEMP 2000, Wolfsburg 13. – 16. |September 2000, www.nova-institut.de
Presentation for Nova-Institute “Online Proceedings”
Third International Symposium: Bioresource Hemp.
13-16 September 2000, Wolfsburg, Germany
Advantages of Polypharmaceutical herbal Cannabis compared to single-ingredient, synthetic tetrahydrocannabinol
John McPartland
Vermont Alternative Medicine / AMRITA
53 Washington Street Ext.
Middlebury, VT 05753 USA
Introduction
In the United States, marijuana (cannabis sativa, possibly also Cannabis indica and Cannabis afghanica) is classified by the Drug Enforcement Administration (DEA) as prohibited Schedule 1 drug (“no currently accepted medical use”). As a substitute for marijuana, the DEA approved dronabinol (Marinol). Dronabinol is synthetic deltra-9-tetrahydrocannabinol). It is formulated in a capsule, designed for oral administration. Because Delta 9 is the primary psychoactive ingredient in both Dronabinol and marijuana, the DEA considers Dronabinol equal to marijuana in effectiveness, for the treatment of nausea, vomitting, and anorexia.
(This is great PDF ebook that explains more about the safety of THC as medicine pick it up below)
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.